310 related articles for article (PubMed ID: 3878521)
1. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521
[TBL] [Abstract][Full Text] [Related]
2. Myasthenogenicity of human acetylcholine receptor synthetic alpha-subunit peptide 125-147 does not require intramolecular disulfide cyclization.
McCormick DJ; Griesmann GE; Huang ZX; Lambert EH; Lennon VA
J Immunol; 1987 Oct; 139(8):2615-9. PubMed ID: 3498765
[TBL] [Abstract][Full Text] [Related]
3. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618
[TBL] [Abstract][Full Text] [Related]
4. Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit.
Hohlfeld R; Toyka KV; Tzartos SJ; Carson W; Conti-Tronconi BM
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5379-83. PubMed ID: 2955417
[TBL] [Abstract][Full Text] [Related]
5. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
[TBL] [Abstract][Full Text] [Related]
6. Definition of myasthenogenic sites of the human acetylcholine receptor using synthetic peptides.
Lennon VA; Griesmann GA; McCormick DJ; Huang ZX; Feng H; Lambert EH
Ann N Y Acad Sci; 1987; 505():439-50. PubMed ID: 2446556
[TBL] [Abstract][Full Text] [Related]
7. Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor.
Bartfeld D; Fuchs S
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):4006-10. PubMed ID: 279016
[TBL] [Abstract][Full Text] [Related]
8. The alpha-bungarotoxin binding site on the nicotinic acetylcholine receptor: analysis using a phage-epitope library.
Balass M; Katchalski-Katzir E; Fuchs S
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6054-8. PubMed ID: 9177167
[TBL] [Abstract][Full Text] [Related]
9. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit.
Barchan D; Souroujon MC; Im SH; Antozzi C; Fuchs S
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8086-91. PubMed ID: 10393952
[TBL] [Abstract][Full Text] [Related]
11. Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.
Venkatesh N; Im SH; Balass M; Fuchs S; Katchalski-Katzir E
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):761-6. PubMed ID: 10639153
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
[TBL] [Abstract][Full Text] [Related]
13. Myasthenogenic significance of synthetic alpha-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor.
Takamori M; Okumura S; Nagata M; Yoshikawa H
J Neurol Sci; 1988 Jun; 85(2):121-9. PubMed ID: 3260271
[TBL] [Abstract][Full Text] [Related]
14. Conformational modification enhances myasthenogenicity in synthetic peptide of acetylcholine receptor alpha-subunit.
Takamori M; Okumura S; Komai K; Satake R
J Neurol Sci; 1990 Nov; 99(2-3):219-27. PubMed ID: 2086725
[TBL] [Abstract][Full Text] [Related]
15. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats.
Baggi F; Annoni A; Ubiali F; Milani M; Longhi R; Scaioli W; Cornelio F; Mantegazza R; Antozzi C
J Immunol; 2004 Feb; 172(4):2697-703. PubMed ID: 14764745
[TBL] [Abstract][Full Text] [Related]
16. Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis.
Wassermann NH; Penn AS; Freimuth PI; Treptow N; Wentzel S; Cleveland WL; Erlanger BF
Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4810-4. PubMed ID: 6181515
[TBL] [Abstract][Full Text] [Related]
17. Immunisation with Torpedo acetylcholine receptor.
Elfman L
Prog Neurobiol; 1984; 23(1-2):39-62. PubMed ID: 6097937
[TBL] [Abstract][Full Text] [Related]
18. Anti-acetylcholine receptor antibodies in myasthenia gravis: binding to membrane-bound Torpedo AChR.
Koethe SM; DuPont BL; Calvo AM; Otterson G; McQuillen MP
Ann N Y Acad Sci; 1987; 505():557-65. PubMed ID: 3479936
[No Abstract] [Full Text] [Related]
19. Myasthenia gravis: effect on antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptor.
Wahlsten JL; Lindstrom JM; Ostlie N; Wu XD; Conti-Tronconi BM
J Recept Res; 1993; 13(5):863-79. PubMed ID: 8463998
[TBL] [Abstract][Full Text] [Related]
20. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
Fujii Y; Lindstrom J
J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
